tiprankstipranks
Actinium Pharmaceuticals (DE:7AY1)
FRANKFURT:7AY1
Germany Market

Actinium Pharmaceuticals (7AY1) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Actinium Pharmaceuticals’s (7AY1) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting Actinium Pharmaceuticals is a Sell.
Actinium Pharmaceuticals’s (7AY1) 20-Day exponential moving average is 0.82, while Actinium Pharmaceuticals’s (7AY1) share price is €0.71, making it a Buy.
Actinium Pharmaceuticals’s (7AY1) 50-Day exponential moving average is 0.82, while Actinium Pharmaceuticals’s (7AY1) share price is €0.71, making it a Buy.

Actinium Pharmaceuticals (7AY1) Pivot Points

Aug 28, 2026, 03:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.88
0.88
0.88
0.88
0.88
0.88
0.88
Fibonacci
0.88
0.88
0.88
0.88
0.88
0.88
0.88
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Actinium Pharmaceuticals (7AY1) Moving Averages

Aug 28, 2026, 03:13 PM
Period
Simple
Exponential
MA5
0.92Sell
0.90Buy
MA10
0.87Buy
0.87Buy
MA20
0.78Buy
0.82Buy
MA50
0.80Buy
0.82Buy
MA100
0.90Buy
0.87Buy
MA200
0.98Sell
0.99Sell
Actinium Pharmaceuticals’s (7AY1) 10-Day exponential moving average is 0.87, while Actinium Pharmaceuticals’s (7AY1) share price is €0.71, making it a Buy.
Actinium Pharmaceuticals’s (7AY1) 100-Day exponential moving average is 0.87, while Actinium Pharmaceuticals’s (7AY1) share price is €0.71, making it a Buy.
Actinium Pharmaceuticals’s (7AY1) stock price is €0.71 and Actinium Pharmaceuticals’s (7AY1) 50-day simple moving average is 0.80, creating a Buy signal.
Actinium Pharmaceuticals’s (7AY1) stock price is €0.71 and Actinium Pharmaceuticals’s (7AY1) 100-day simple moving average is 0.90, creating a Buy signal.
Actinium Pharmaceuticals’s (7AY1) stock price is €0.71 and Actinium Pharmaceuticals’s (7AY1) 200-day simple moving average is 0.98, creating a Sell signal.

Actinium Pharmaceuticals (7AY1) Technical Indicators

Aug 28, 2026, 03:13 PM
Name
Value
Implied Action
RSI (14)
63.14
Neutral
STOCH (9,6)
79.55
Neutral
STOCHRSI (14)
86.76
Sell
MACD (12,26)
0.04
Sell
ADX (14)
30.57
Neutral
Williams %R
-12.29
Sell
CCI (14)
83.06
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
65.03
Neutral
ROC
43.22
Buy
Actinium Pharmaceuticals’s (7AY1) Relative Strength Index (RSI) is 63.14, creating a Neutral signal.
Actinium Pharmaceuticals’s (7AY1) Trend Strength Indicator (ADX) is 30.57, creating a Neutral signal.
Actinium Pharmaceuticals’s (7AY1) Commodity Channel Index (CCI) is 83.06, creating a Neutral signal.
Actinium Pharmaceuticals’s (7AY1) Price Rate of Change (ROC) is 43.22, creating a Buy signal.

FAQ

Is 7AY1 a Buy, Hold, or Sell?
Based on 7AY1’s technical indicators, 7AY1 is a Buy.
    What is 7AY1’s RSI (14)?
    7AY1’s RSI (14) is 63.14, which suggests 7AY1 is a Neutral.
      What is 7AY1’s MACD?
      7AY1’s MACD is 0.04, which suggests 7AY1 is a Sell.
        What is 7AY1’s 5-day moving average?
        7AY1’s 5-day moving average is 0.92, which suggests 7AY1 is a Sell.
          What is 7AY1’s 20-day moving average?
          7AY1 20-day moving average is 0.78, which suggests 7AY1 is a Buy.
            What is 7AY1’s 50-day moving average?
            7AY1’s 50-day moving average is 0.80, which suggests 7AY1 is a Buy.
              What is 7AY1’s 200-day moving average?
              7AY1’s 200-day moving average is 0.98, which suggests 7AY1 is a Sell.
                What is 7AY1’s Williams % R (14)?
                7AY1’s Williams % R (14) is -12.29, which suggests 7AY1 is a Sell.
                  What is 7AY1’s CCI (14)?
                  7AY1’s CCI (14) is 83.06, which suggests 7AY1 is a Neutral.
                    What is the share price of Actinium Pharmaceuticals?